Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 174.85 Bil Enterprise Value: 226.24 Bil PE Ratio: 41.65 PB Ratio: 23.23 GF Score: 91/100

Q1 2023 Amgen Inc Earnings Call Transcript

Apr 27, 2023 / 08:30PM GMT
Release Date Price: $236.5 (-1.25%)
Operator

My name is Julie Anne, and I will be your conference facilitator today for Amgen's First Quarter Full Year 2023 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Thank you, Julie Anne. Good afternoon, everyone, and welcome to our call to discuss our results for the first quarter of 2023.

Strong unit volume growth that sets up the stage nicely for improved outlook for the balance of the year, these are some of the key themes that you're going to hear about today.

Our Chairman and CEO, Bob Bradway, will lead the call with some prepared remarks followed by a broader review of our performance by other members of our leadership team. You should have received a link to our slides that we have posted.

Through the course of our discussion today, we will make some forward-looking statements and use non-GAAP financial measures to describe our performance, and just a reminder that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot